openPR Logo
Press release

Chronic Rhinosinusitis with Nasal Polyps Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | AstraZeneca, Amgen, Pfizer, Trellis Bioscience, GSK, Insmed, Lyra Therapeutics

05-15-2024 07:52 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Chronic Rhinosinusitis with Nasal Polyps Pipeline

Chronic Rhinosinusitis with Nasal Polyps Pipeline

(Albany, USA) As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Chronic Rhinosinusitis with Nasal Polyps therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Chronic Rhinosinusitis with Nasal Polyps Pipeline Insight 2024" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Chronic Rhinosinusitis with Nasal Polyps Therapeutics Market.

The report provides a detailed description of Chronic Rhinosinusitis with Nasal Polyps drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Chronic Rhinosinusitis with Nasal Polyps Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Chronic Rhinosinusitis with Nasal Polyps Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Chronic Rhinosinusitis with Nasal Polyps therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Chronic Rhinosinusitis with Nasal Polyps treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Chronic Rhinosinusitis with Nasal Polyps drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Chronic Rhinosinusitis with Nasal Polyps treatment market.

Learn More about the Clinical and Commercial Development Activities in the Chronic Rhinosinusitis with Nasal Polyps Therapeutics Domain @
https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Chronic Rhinosinusitis with Nasal Polyps Therapeutics Analysis
The standard treatment for CRSwNP includes a combination of pharmacological and surgical approaches depending on individual case assessment. In general, patients are treated medically in the primary care setting before considering surgical procedures. Treatment aims to eliminate or significantly reduce the size of the nasal polyp, resulting in relief of nasal obstruction, improvement in sinus drainage, restoration of olfaction and taste. Treatment of any accompanying rhinitis symptoms may also be required. With both treatments, recurrences are common, particularly in patients with asthma who are twice as likely to develop recurrence compared with nonasthmatics.

The current treatment of CRSwNP includes corticosteroids (intranasal and systemic) in addition to anti-histamines, antibiotics, and NSAIDs depending upon the patient's need. Over the years the US FDA has approved corticosteroids along with Biologics for the treatment of CRSwNP which includes DUPIXENT (dupilumab), XOLAIR (omalizumab), NUCALA (mepolizumab). However the use of biologics are usually restricted to severe CRSwNP patients. Other treatment options include, XHANCE (fluticasone propionate), SINUVA (mometasone furoate) Sinus Implant, PROPEL (mometasone furoate),

There are approx. 10+ key companies developing therapies for Chronic Rhinosinusitis with Nasal Polyps. Currently, Keymed Biosciences is leading the therapeutics market with its Chronic Rhinosinusitis with Nasal Polyps drug candidates in the most advanced stage of clinical development.

Chronic Rhinosinusitis with Nasal Polyps Companies in the Therapeutics Market Include:
• Keymed Biosciences
• Connect Biopharma
• AstraZeneca
• Amgen
• Pfizer
• Trellis Bioscience LLC
• GlaxoSmithKline
• Gossamer BioInc.
• Biohaven Pharmaceuticals, Inc.
• Insmed Incorporated
• Lyra Therapeutics
And Many Others

Emerging and Marketed Chronic Rhinosinusitis with Nasal Polyps Therapies Covered in the Report Include:
• CM310: Keymed Biosciences
• CBP 201: Connect Biopharma
And Many More

Get an in-depth Assessment of the Emerging Therapies and Chronic Rhinosinusitis with Nasal Polyps Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/chronic-rhinosinusitis-with-nasal-polyps-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

The Report Covers the Emerging Chronic Rhinosinusitis with Nasal Polyps Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Chronic Rhinosinusitis with Nasal Polyps pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Inhalation
• Inhalation/Intravenous/Oral
• Intranasal
• Intravenous
• Intravenous/ Subcutaneous
• Oral
• Oral/intranasal/subcutaneous
• Parenteral
• Subcutaneous

Molecule Type
Products have been categorized under various Molecule types such as
• Antibody
• Antisense oligonucleotides
• Immunotherapy
• Monoclonal antibody
• Peptides
• Protein
• Recombinant protein
• Small molecule
• Stem Cell
• Vaccine

Request for Sample PDF to Understand More About the Chronic Rhinosinusitis with Nasal Polyps Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/chronic-rhinosinusitis-with-nasal-polyps-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Content
1. Report Introduction
2. Executive Summary
3. Chronic Rhinosinusitis with Nasal Polyps Current Treatment Patterns
4. Chronic Rhinosinusitis with Nasal Polyps - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Chronic Rhinosinusitis with Nasal Polyps Late-Stage Products (Phase-III)
7. Chronic Rhinosinusitis with Nasal Polyps Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Chronic Rhinosinusitis with Nasal Polyps Discontinued Products
13. Chronic Rhinosinusitis with Nasal Polyps Product Profiles
14. Chronic Rhinosinusitis with Nasal Polyps Companies
15. Chronic Rhinosinusitis with Nasal Polyps Drugs
16. Dormant and Discontinued Products
17. Chronic Rhinosinusitis with Nasal Polyps Unmet Needs
18. Chronic Rhinosinusitis with Nasal Polyps Future Perspectives
19. Chronic Rhinosinusitis with Nasal Polyps Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/chronic-rhinosinusitis-with-nasal-polyps-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Trending Reports:
• Acute Pain Market: https://www.delveinsight.com/report-store/acute-pain-market
• Alopecia Aerata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Neuromodulation Devices Market: https://www.delveinsight.com/report-store/neuromodulation-devices-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Brain Cancer Market: https://www.delveinsight.com/report-store/brain-cancer-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Adult Growth Hormone Deficiency Market: https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market
• Biliary Tumor Market: https://www.delveinsight.com/report-store/biliary-tumor-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
• Emesis Market: https://www.delveinsight.com/report-store/emesis-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Reactive Arthritis Market: https://www.delveinsight.com/report-store/reactive-arthritis-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Airway Stent Market Market: https://www.delveinsight.com/report-store/airway-stent-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Asphyxia Market: https://www.delveinsight.com/report-store/asphyxia-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Vitamin A Deficiency Market: https://www.delveinsight.com/report-store/vitamin-a-deficiency-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/asco-conference-coverage

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Rhinosinusitis with Nasal Polyps Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | AstraZeneca, Amgen, Pfizer, Trellis Bioscience, GSK, Insmed, Lyra Therapeutics here

News-ID: 3498116 • Views:

More Releases from DelveInsight Business Research

Advanced Ovarian Cancer Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical Trials, Epidemiology, Therapies, Companies by DelveInsight | Oregovomab, Stenoparib, DP-303c, more.
Advanced Ovarian Cancer Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical …
As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Advanced Ovarian Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Advanced Ovarian Cancer Pipeline Insight, 2024" report by DelveInsight provides a
Angio-immunoblastic T-cell Lymphoma Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical Trials, Epidemiology, Therapies, Companies by DelveInsight
Angio-immunoblastic T-cell Lymphoma Market Forecast 2032: FDA, EMA, PDMA Approva …
(Albany, USA) DelveInsight's "Angio-immunoblastic T-cell Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Angio-immunoblastic T-cell Lymphoma, historical and forecasted epidemiology as well as the Angio-immunoblastic T-cell Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Angio-immunoblastic T-cell Lymphoma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and
Hemophagocytic Lymphohistiocytosis Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical Trials, Epidemiology, Therapies, Companies by DelveInsight
Hemophagocytic Lymphohistiocytosis Market Forecast 2032: FDA, EMA, PDMA Approval …
(Albany, USA) DelveInsight's "Hemophagocytic Lymphohistiocytosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hemophagocytic Lymphohistiocytosis, historical and forecasted epidemiology as well as the Hemophagocytic Lymphohistiocytosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Hemophagocytic Lymphohistiocytosis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Hemophagocytic Lymphohistiocytosis market
Hypercholesterolaemia Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Tafolecimab, Ebronucimab, more
Hypercholesterolaemia Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Th …
(Albany, USA) As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in the Hypercholesterolaemia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Hypercholesterolaemia Pipeline Insight, 2024" report by DelveInsight provides a comprehensive analysis

All 5 Releases


More Releases for Chronic

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Reviewed, …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market Res …
Latest industry research report on: Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them
11-10-2016 | Health & Medicine
MRR.biz
Global Chronic, Acute, And Neuropathic Pain Market: Opioids To Remain Most Value …
The research report, titled “Frontier Pharma: Chronic, Acute And Neuropathic Pain - GPCR And Nerve Growth Factor-Based Therapies Offer Strong Potential In Difficult-To-Treat Subtypes,” analyzes the historical as well as the existing performance of this market, emphasizing specifically on various types of therapies applied to treat chronic, acute, and neuropathic pain. According to this 68-page study, the worldwide market for chronic, acute, and neuropathic pain has been observing a significant
Targeting chronic pain
With the support of the Austrian Science Fund FWF, the neurophysiologist Ruth Drdla-Schutting is investigating the role astrocytes play in the genesis of chronic pain. With the help of innovative gene technology (DREADDs), scientists are tailoring treatment specifically to these cells that are the most numerous found in the central nervous system. Pain is an important protection system of the human body. But when it becomes chronic, as it frequently